The Royal Wolverhampton NHS Trust

Dr. Francesco Manfredonia is a Clinical Director Neurology and Neurophysiology at the Royal Wolverhampton National Health Service Trust, specialising in epilepsy and clinical neurophysiology. With over 15 years of experience in the United Kingdom and Italy, he leads epilepsy services, reports on complex electroencephalogram studies and delivers acute neurophysiological care. He earned his Doctor of Medicine degree with top honours from the University of Pisa and has held senior roles in hospital neurology and pharmaceutical research.

Reframing Neurological Care around Systems, Not Silos

Manfredonia’s career has never been limited to clinical diagnosis or episodic care. Across more than 15 years in the UK and Italy, he has come to view neurology not as a standalone speciality, but as a system needing constant design, where the structure of care delivery matters just as much as the expertise behind it.

Too often, neurological services fall into reactive patterns when responding to acute events, managing symptoms and navigating resource gaps. For Manfredonia, the question has always been different: How can care be structured to prevent crisis, support transitions and function at scale? His answer lies in building systems that respond to needs and anticipate them.

Designing Pathways That Endure

That philosophy took form during his work reshaping epilepsy services, where he led efforts to build integrated care from the ground up. What mattered most wasn’t simply setting up clinics— it was defining what a sustainable service should look like: one that links diagnostics to treatment, supports long-term outcomes and eliminates the fragmentation that often delays care.

Manfredonia’s model blends strategic design with frontline insight. He looks beyond protocols to uncover structural weaknesses and then rebuilds care around clinical relevance and operational viability. Whether addressing gaps in seizure response or planning smoother transitions across care stages, he prioritises frameworks that remain flexible, scalable and rooted in patient realities.

Making Neurophysiology Actionable

For neurological care to be effective, it must move as fast as the conditions it treats. Manfredonia has consistently worked to embed advanced neurophysiological tools—like EEG, sleep studies, video telemetry and EMG—into the flow of real-time clinical decision-making. To him, these tools are not just diagnostics; they are levers for earlier intervention, greater clarity and more confident treatment in settings where time is critical.

This is particularly vital in emergency and intensive care environments, where ambiguity can compromise outcomes. Manfredonia’s approach places neurology at the centre of acute care decision-making—turning data into insight and insight into immediate action.

Bridging Expertise with Accessibility

Clinical knowledge alone doesn’t change systems—translating it does. With leadership experience spanning multiple sclerosis programmes, neuroimaging innovation and day-case neurology services, Manfredonia has developed a rare ability to simplify complexity without losing nuance. This clarity allows him to align stakeholders, train future clinicians and elevate neurology within broader care strategies.

His commitment to teaching reflects this belief. At Queen Elizabeth Hospital Birmingham and through ongoing mentorship, he actively builds the next generation of neurologists and neurophysiology leaders to expand capability and instil a mindset combining precision and pragmatism.

Looking Ahead: Adaptive Systems for a Dynamic Future

As neurological conditions become more complex and demand continues to rise, Manfredonia sees the future not in new technologies alone but in how well services can adapt to them. The challenge isn’t just innovation—it’s integration. Systems must evolve to meet emerging needs without losing sight of the human experience at their core.

Through every initiative he leads, Manfredonia reinforces a simple but powerful idea: neurology must be reimagined not just as a set of treatments, but as an ecosystem—designed with foresight, delivered with speed and built to serve across lifetimes, not just episodes.